blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3042895

EP3042895 - PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.04.2018
Database last updated on 13.07.2024
FormerGrant of patent is intended
Status updated on  20.07.2017
FormerRequest for examination was made
Status updated on  27.01.2017
Most recent event   Tooltip20.04.2018Application deemed to be withdrawnpublished on 23.05.2018  [2018/21]
Applicant(s)For all designated states
Xenon Pharmaceuticals Inc.
3650 Gilmore Way
Burnaby, BC V5G 4W8 / CA
[2016/28]
Inventor(s)01 / Abreo, Melwyn
3373 Armagosa Way
Jamul, CA 91932 / US
02 / Chafev, Mikhail
2919 East 56th Avenue
Vancouver, BC V5S 2A2 / CA
03 / Chakka, Nagasree
13 Judith Lane
Waltham, MA 02452 / US
04 / Chowdhury, Sultan
97 Orleans Drive
Ontario
Scarborough, M1C 4Y3 / CA
05 / Fu, Jian-Min
3170 Qintette Crescent
Coquitian, BC V3E 3B6 / CA
06 / Gschwend, Heinz W.
161 Meadowcraft Way
Santa Rosa, CA 95403 / US
07 / Holladay, Mark W.
11371 Woodcraft Way
San Diego, CA 92131 / US
08 / Hou, Duanjie
No. 46-7088, 17th Avenue
Burnaby, BC V3N 1K5 / CA
09 / Kamboj, Rajender
5809 Sperling Avenue
Burnaby, BC V5E 2T6 / CA
10 / Kodumuru, Vishnumurthy
13 Judith Lane
Waltham, MA 02452 / US
11 / Li, Wenbao
11674 Castile Way
San Diego, CA 92128 / US
12 / Liu, Shifeng
15-2615 Fortress Drive
Port Coquitlam, BC V3C 6E8 / CA
13 / Raina, Vandna
PH3, 2763 Chandlery Place
Vancouver, BC V5S 4V4 / CA
14 / Sun, Sengen
8838 La Camesa Street
San Diego, CA 92129 / US
15 / Sun, Shaoyi
No.5-1200 Brunette Avenue
Coquitlam, BC V3K 1G3 / CA
16 / Sviridov, Serguei
1904-5885 Olive Avenue
Burnaby, BC V5H 4N8 / CA
17 / Tu, Chi
5269 Quaker Hill Lane
San Diego, CA 92130 / US
18 / Winther, Michael D.
1935 West 4th Avenue
Vancouver, BC V6J 2K1 / CA
19 / Zhang, Zaihui
4038 MacDonald Street
Vancouver, BC V6L 2N9 / CA
 [2017/33]
Former [2016/28]01 / Abreo, Melwyn
3373 Armagosa Way
Jamul, CA 91932 / US
02 / Chafev, Mikhail
2919 East 56th Avenue
BC
Vancouver, V5S 2A2 / CA
03 / Chakka, Nagasree
13 Judith Lane
Waltham, MA 02452 / US
04 / Chowdhury, Sultan
97 Orleans Drive
Ontario
Scarborough, M1C 4Y3 / CA
05 / FU, Jian-Min
3170 Qintette Crescent
Coquitian
British Columbia V3E 3B6 / CA
06 / Gschwend, Heinz W.
161 Meadowcraft Way
Santa Rosa, CA 95403 / US
07 / Holladay, Mark W.
11371 Woodcraft Way
San Diego, CA 92131 / US
08 / HOU, Duanjie
No. 46-7088, 17th Avenue
BC
Burnaby, V3N 1K5 / CA
09 / Kamboj, Rajender
5809 Sperling Avenue
BC
Burnaby, V5E 2T6 / CA
10 / Kodumuru, Vishnumurthy
13 Judith Lane
Waltham, MA 02452 / US
11 / LI, Wenbao
11674 Castile Way
San Diego, CA 92128 / US
12 / LIU, Shifeng
15-2615 Fortress Drive
BC
Port Coquitlam, V3C 6E8 / CA
13 / Raina, Vandna
PH3, 2763 Chandlery Place
BC
Vancouver, V5S 4V4 / CA
14 / SUN, Sengen
8838 La Camesa Street
San Diego, CA 92129 / US
15 / SUN, Shaoyi
No.5-1200 Brunette Avenue
BC
Coquitlam, V3K 1G3 / CA
16 / Sviridov, Serguei
1904-5885 Olive Avenue
BC
Burnaby, V5H 4N8 / CA
17 / TU, Chi
5269 Quaker Hill Lane
San Diego, CA 92130 / US
18 / Winther, Michael D.
1935 West 4th Avenue
BC
Vancouver, V6J 2K1 / CA
19 / Zhang, Zaihui
4038 MacDonald Street
BC
Vancouver, V6L 2N9 / CA
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2016/28]
Application number, filing date16000190.529.07.2004
[2016/28]
Priority number, dateUS20030491095P30.07.2003         Original published format: US 491095 P
US20040546898P23.02.2004         Original published format: US 546898 P
US20040546934P23.02.2004         Original published format: US 546934 P
US20040546815P23.02.2004         Original published format: US 546815 P
US20040546820P23.02.2004         Original published format: US 546820 P
US20040546786P23.02.2004         Original published format: US 546786 P
US20040553403P16.03.2004         Original published format: US 553403 P
US20040553446P16.03.2004         Original published format: US 553446 P
US20040553491P16.03.2004         Original published format: US 553491 P
US20040553416P16.03.2004         Original published format: US 553416 P
US20040553404P16.03.2004         Original published format: US 553404 P
[2016/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3042895
Date:13.07.2016
Language:EN
[2016/28]
Search report(s)(Supplementary) European search report - dispatched on:EP05.04.2016
ClassificationIPC:C07D237/20, C07D237/22, A61K31/501, A61P3/06
[2016/28]
CPC:
A61K31/00 (EP,US); A61K31/501 (EP,KR,US); A61K31/551 (EP,US);
A61P1/16 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P43/00 (EP);
A61P5/50 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); C07D237/20 (EP,KR,US); C07D237/24 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/09]
Former [2016/28]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL13.01.2017
HR13.01.2017
LT13.01.2017
LV13.01.2017
MK13.01.2017
TitleGerman:PYRIDAZINDERIVATE UND DEREN VERWENDUNG ALS THERAPEUTISCHE WIRKSTOFFE[2016/28]
English:PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS[2016/28]
French:DÉRIVÉS DE LA PIPÉRAZINE ET LEUR UTILISATION EN TANT QU'AGENTS THÉRAPEUTIQUES[2016/28]
Examination procedure25.01.2016Date on which the examining division has become responsible
13.01.2017Amendment by applicant (claims and/or description)
13.01.2017Examination requested  [2017/09]
21.07.2017Communication of intention to grant the patent
01.12.2017Application deemed to be withdrawn, date of legal effect  [2018/21]
09.01.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2018/21]
Parent application(s)   TooltipEP04779562.0  / EP1648874
EP10184939.6  / EP2316827
Fees paidRenewal fee
25.01.2016Renewal fee patent year 03
25.01.2016Renewal fee patent year 04
25.01.2016Renewal fee patent year 05
25.01.2016Renewal fee patent year 06
25.01.2016Renewal fee patent year 07
25.01.2016Renewal fee patent year 08
25.01.2016Renewal fee patent year 09
25.01.2016Renewal fee patent year 10
25.01.2016Renewal fee patent year 11
25.01.2016Renewal fee patent year 12
27.07.2016Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
31.07.201714   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9726258  (JANSSEN PHARMACEUTICA NV [BE], et al) [Y] 1,4 * pages 6-7 *;
 [A]WO0162954  (XENON GENETICS INC [CA], et al) [A] 1-4* page 51 *;
 [Y]WO0210154  (LILLY CO ELI [US], et al) [Y] 1,4 * pages 11-12 * * pages 65-69 * * pages 119,121 * * pages 102-105 *
by applicantWO0162954
 WO0226944
 WO03075929
 WO03076400
 WO03076401
 US6677452
    - JEFFCOAT, R. ET AL., ELSEVIER SCIENCE, (1984), vol. 4, pages 85 - 112
    - DE ANTUENO, RJ, LIPIDS, (1993), vol. 28, no. 4, pages 285 - 290
    - ATTIE, A.D ET AL., "Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia", J. LIPID RES., (2002), vol. 43, no. 11, pages 1899 - 907
    - COHEN, P. ET AL., "Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss", SCIENCE, (2002), vol. 297, no. 5579, pages 240 - 3
    - NTAMBI, J. M ET AL., "Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity", PROC. NATL. ACAD. SCI. USA., (2002), vol. 99, no. 7, pages 11482 - 6
    - BUNDGARD, H., Design of Prodrugs, ELSEVIER, (1985), pages 7 - 9,21-24
    - "Pro-drugs as Novel Delivery Systems", HIGUCHI, T. ET AL., A.C.S. Symposium Series, vol. 14
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.